GPT and familial hypercholesterolemia: Non-hematologic toxicities predominated, primarily grade 1–2 hyperbilirubinemia (28.1%), ALT elevation (26.4%), and hypercholesterolemia (24.0%), with only 0.8% progressing to grade 3–4 for each.